Globus Medical, Inc.
GMED
$71.04
$1.361.95%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.19% | -42.05% | -80.09% | -66.89% | -35.39% |
| Total Depreciation and Amortization | 75.51% | 183.99% | 221.77% | 161.62% | 112.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 182.39% | 484.27% | 622.88% | 420.13% | 265.45% |
| Change in Net Operating Assets | 16.33% | -97.70% | -75.90% | -26.71% | -10.77% |
| Cash from Operations | 113.82% | 104.62% | 41.33% | 29.66% | 36.44% |
| Capital Expenditure | -47.47% | -64.38% | -57.02% | -29.66% | -5.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 94.04% | 94.60% | -844.36% | -824.60% | -841.71% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -106.35% | 20.39% | 1,518.76% | 3,531.04% | 13,978.48% |
| Cash from Investing | -158.11% | 418.29% | 402.74% | 387.09% | 374.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 790.85% | 57.18% | -42.80% | -71.80% | -70.28% |
| Repurchase of Common Stock | 60.83% | -- | -- | -124.81% | -63.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -467.47% | -401.40% | -394.73% | -394.19% | -11.89% |
| Cash from Financing | 88.05% | -1,805.35% | -1,214.00% | -209.97% | -110.82% |
| Foreign Exchange rate Adjustments | -88.30% | 147.99% | 4,653.19% | -70.15% | 391.83% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.10% | 136.01% | -33.21% | 1,226.71% | 843.67% |
